These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32224905)

  • 1. Nanoantioxidant-Based Silica Particles as Flavonoid Carrier for Drug Delivery Applications.
    Arriagada F; Günther G; Morales J
    Pharmaceutics; 2020 Mar; 12(4):. PubMed ID: 32224905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of silica-coated insulin-loaded chitosan nanoparticles as a promising oral administration system.
    Fathy MM; Hassan AA; Elsayed AA; Fahmy HM
    BMC Pharmacol Toxicol; 2023 Mar; 24(1):21. PubMed ID: 36998008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface engineered mesoporous silica carriers for the controlled delivery of anticancer drug 5-fluorouracil: Computational approach for the drug-carrier interactions using density functional theory.
    Rehman F; Khan AJ; Sama ZU; Alobaid HM; Gilani MA; Safi SZ; Muhammad N; Rahim A; Ali A; Guo J; Arshad M; Emran TB
    Front Pharmacol; 2023; 14():1146562. PubMed ID: 37124235
    [No Abstract]   [Full Text] [Related]  

  • 4. Inclusion of fenofibrate in a series of mesoporous silicas using microwave irradiation.
    Waters LJ; Hussain T; Parkes G; Hanrahan JP; Tobin JM
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):936-41. PubMed ID: 23954510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic synthesized nanoporous silica@poly(ethyleneimine)s xerogel as drug carrier: characteristics and controlled release effect.
    Li J; Xu L; Liu H; Wang Y; Wang Q; Chen H; Pan W; Li S
    Int J Pharm; 2014 Jun; 467(1-2):9-18. PubMed ID: 24674897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminescent porous silica fibers as drug carriers.
    Hou Z; Zhang C; Li C; Xu Z; Cheng Z; Li G; Wang W; Peng C; Lin J
    Chemistry; 2010 Dec; 16(48):14513-9. PubMed ID: 21077051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and in vitro release study of gallic acid loaded silica nanoparticles for controlled release.
    Hu H; Nie L; Feng S; Suo J
    Pharmazie; 2013 Jun; 68(6):401-5. PubMed ID: 23875245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics.
    Kassem AM; Almukainzi M; Faris TM; Ibrahim AH; Anwar W; Elbahwy IA; El-Gamal FR; Zidan MF; Akl MA; Abd-ElGawad AM; Elshamy AI; Elmowafy M
    Eur J Pharm Sci; 2024 Jan; 192():106652. PubMed ID: 38008226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
    Amin MK; Boateng JS
    Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
    Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
    Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery.
    Peyvand P; Vaezi Z; Sedghi M; Dalir N; Ma'mani L; Naderi-Manesh H
    Pharm Dev Technol; 2020 Nov; 25(9):1150-1161. PubMed ID: 32746669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tannic acid-templated mesoporous silica nanoparticles on iron-induced oxidative stress and liver toxicity in rats.
    Javdani H; Etemad L; Moshiri M; Zarban A; Hanafi-Bojd MY
    Toxicol Rep; 2021; 8():1721-1728. PubMed ID: 34692422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery.
    Fateh Basharzad S; Hamidi M; Maleki A; Karami Z; Mohamadpour H; Reza Saghatchi Zanjani M
    Brain Res; 2022 Apr; 1781():147786. PubMed ID: 35041841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of pH-Responsive Biodegradable Mesoporous Silica-Calcium Phosphate Hybrid Nanoparticles as a High Potential Drug Carrier.
    He Y; Zeng B; Liang S; Long M; Xu H
    ACS Appl Mater Interfaces; 2017 Dec; 9(51):44402-44409. PubMed ID: 29215868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
    Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified magnetic core-shell mesoporous silica nano-formulations with encapsulated quercetin exhibit anti-amyloid and antioxidant activity.
    Halevas E; Mavroidi B; Nday CM; Tang J; Smith GC; Boukos N; Litsardakis G; Pelecanou M; Salifoglou A
    J Inorg Biochem; 2020 Dec; 213():111271. PubMed ID: 33069945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDTA-modified mesoporous silica as supra adsorbent of copper ions with novel approach as an antidote agent in copper toxicity.
    Taqanaki ER; Heidari R; Monfared M; Tayebi L; Azadi A; Farjadian F
    Int J Nanomedicine; 2019; 14():7781-7792. PubMed ID: 31576122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.